These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9742479)

  • 1. Triazole therapy for mucocutaneous candidiasis in HIV-infected patients.
    Thomas CJ
    J Assoc Nurses AIDS Care; 1998; 9(5):36-44. PubMed ID: 9742479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Candida infection of the skin and mucous membranes still a topic. Administering azoles with clinical understanding].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():80. PubMed ID: 12043087
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole-resistant Candida albicans.
    Boken DJ; Swindells S; Rinaldi MG
    Clin Infect Dis; 1993 Dec; 17(6):1018-21. PubMed ID: 8110924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant candidiasis.
    Powderly WG
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):925-9. PubMed ID: 7811544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal infection overview.
    Treat Rev; 1995 May; (no 18):10. PubMed ID: 11362589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
    De Wit S; O'Doherty E; De Vroey C; Clumeck N
    J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Barbarini G; Di Lorenzo G
    Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
    Penzak SR; Gubbins PO
    Am J Health Syst Pharm; 1998 Feb; 55(3):279-83. PubMed ID: 9492260
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Di Lorenzo G
    Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
    Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oropharyngeal and esophageal candidiasis in HIV disease: emerging pathogens, changing therapies.
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S1-25; quiz S26-7. PubMed ID: 11361744
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antifungal agent resistance of yeasts of clinical significance].
    Odds FC
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: a critical reassessment.
    Powderly WG; Mayer KH; Perfect JR
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1405-12. PubMed ID: 10555102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.